ArticlePest management science2026
Design, synthesis, and quantitative structure-antifungal activity relationship of 1,2,4-oxadiazole-containing mappicine derivatives against phytopathogenic fungi.
Article in Pest management science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
backgroundFungal diseases in crops have become a growing major threat to global agriculture, causing substantial yield and economic losses. To address the critical demand for effective antifungal agents against phytopathogenic fungi, a series of mappicine derivatives incorporating a 1,2,4-oxadiazole moiety were rationally designed and synthesized in this study using an active substructure fusion strategy, followed by systematic evaluation of their antifungal potential.
resultsBioassay results revealed that most derivatives exhibited broad-spectrum and potent antifungal activity, with exceptional efficacy against Rhizoctonia solani (R. solani). Among them, compound M-25 displayed the strongest antifungal activity against R. solani with an EC
conclusionThis study offers valuable insights for the development of mappicine-based antifungal agents for plant protection. © 2026 Society of Chemical Industry.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.